aod9604 peptide uses AOD-9604 AOD-9604 5mg Research Peptide |
Description
I had asked a rep if there would be a 4th of July sale and I was told no
The largest Phase 2b trial used 0.25, 0.5, and 1 mg/day orally for 24 weeks
Treatment of cells with 10 M 5-amino-1MQ or 7-amino-1MQ and 300 M 2,3-diamino-1MQ for a 24 h period did not impact cell viability (Figure 1)
These combinations target complementary pathways and may provide synergistic metabolic benefits
Lost 3 lbs so far, more energy
More than one way to die: apoptosis, necrosis and reactive oxygen damage
